JAZZ position history
The shares of Jazz Pharmaceuticals (JAZZ) that Krensavage Asset Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2023 Q4: 100,000 shares, $12M, 4.4% of portfolio, New
- 2024 Q1: 101,151 shares, $12M, 5.4% of portfolio, Add +1.2%
- 2024 Q2: 109,076 shares, $12M, 5.3% of portfolio, Add +7.8%
- 2024 Q3: 110,257 shares, $12M, 6.9% of portfolio, Add +1.1%
- 2024 Q4: 216,060 shares, $26M, 15.4% of portfolio, Add +96.0%
- 2025 Q1: 100,703 shares, $13M, 6.9% of portfolio, Reduce −53.4%
- 2025 Q2: 164,816 shares, $17M, 9.3% of portfolio, Add +63.7%
- 2025 Q3: 167,816 shares, $22M, 9.4% of portfolio, Add +1.8%
- 2025 Q4: 167,816 shares, $29M, 10.1% of portfolio
- 2026 Q1: 167,816 shares, $32M, 12.4% of portfolio
- 2026 Q2: 167,816 shares, $40M, 15.4% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|